Induction of histone acetylation in mouse erythroleukemia cells by some organosulfur compounds including allyl isothiocyanate

International Journal of Cancer

Volumn 92, Issue 6, 2001, Pages 784-789

  Lea, Michael A ^a   Randolph, Verrell M ^a   Lee, Jennifer E ^a   DesBordes, Charles ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Allyl isothiocyanate; Histone acetylation; Mouse

Indexed keywords

ALLYL ISOTHIOCYANATE; HISTONE; HISTONE DEACETYLASE; ORGANOSULFUR DERIVATIVE; THIOL; THIOL DERIVATIVE; TRICHOSTATIN A;

ACETYLATION; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ERYTHROLEUKEMIA; GENE INDUCTION; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION;

ACETYLATION; ACETYLTRANSFERASES; ALLYL COMPOUNDS; ANIMALS; BENZIDINES; CELL NUCLEUS; ENZYME INHIBITORS; HEMOGLOBINS; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HISTONES; HUMANS; HYDROXAMIC ACIDS; IMMUNOBLOTTING; ISOTHIOCYANATES; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MICE; SACCHAROMYCES CEREVISIAE PROTEINS; SULFHYDRYL COMPOUNDS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0035876964     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1277     Document Type: Article

References (27)

1. Spencer VA, Davie JR. Role of covalent modifications of histones in regulating gene expression. Gene 1999;240:1-12.
2. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000;403:41-5.
3. Turner BM. Histone acetylation and an epigenetic code. BioEssays 2000;22:836-45.
4. Lea MA, Ayyala US. Differentiating and growth inhibitory effects of diallyl disulfide on cancer cells. Int J Oncol 1997;11:181-6.
5. Lea MA, Randolph VM, Patel M. Increased acetylation of histones induced by diallyl disulfide and structurally related molecules. Int J Oncol 1999;15:347-52.
6. Schiffmann D, Eder E, Neudecker T, Henschler D. Induction of unscheduled DNA synthesis in HeLa cells by allylic compounds. Cancer Lett 1983;20:263-9.
7. Neudecker T, Henschler D. Allyl isothiocyanate is mutagenic in Salmonella typhimurium. Mutation Res 1985;156:33-7.
8. Bechtel D, Henderson L, Proudlock R. Lack of UDS activity in the livers of rats exposed to allylisothiocyanate. Teratogen Carcinogen Mutagen 1998;18:209-17.
9. Hasegawa T, Nisnino H, Iwashima A. Isothiocyanates inhibit cell cycle progression of HeLa cells at G2/M phase. Anticancer Drugs 1993;4:273-9.
10. Musk SR, Johnson IT. Allyl isothiocyanate is selectively toxic to transformed cells of the human colorectal tumour line HT29. Carcinogenesis 1993;14:2079-83.
11. Musk SR, Smith TK, Johnson IT. On the cytotoxicity and genotoxicity of allyl and phenethyl isothiocyanates and their parent glucosinolates sinigrin and gluconasturtin. Mutat Res 1995;348:19-23.
12. Yoshida M, Kijima M, Akita M, Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 1990;265:17174-9.
13. Lea MA. Randolph VM. Induction of reporter gene expression by inhibitors of histone deacetylase. Anticancer Res 1998;18:2717-22.
14. Lea MA, Tulsyan N. Discordant effects of hutyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase. Anticancer Res 1995;15:879-84.
15. Ait-Si-Ali S, Ramirez S, Robin P, Trouche D, Harel-Bellan A. A rapid and sensitive assay for historic acetyl-transferase activity. Nucleic Acids Res 1998;26:3869-70.
16. Lea MA. Organosulfur compounds and cancer. In: American Institute for Cancer Research. Dietary phytochemicals in cancer prevention and treatment. New York: Plenum Press, 1996:147-54.
17. Musk SR, Stephenson P, Smith TK, Stening P, Fyfe D, Johnson IT. Selective toxicity of compounds naturally present in food toward the transformed phenotype of human colorectal cell line HT29. Nutr Cancer 1995;24:289-98.
18. Fenrick R, Hiebert SW. Role of histone deacetylase in acute leukemia. J Cell Biochem 1998;30/31(Suppl):194-202
19. Mahlknecht U, Hoelzer D. Histone acetylation modifiers in the pathogenesis of malignant disease. Mol Med 2000;6:623-44.
20. Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 2000;92:1210-6.
21. Conaway CC, Jiao D, Chung FL. Inhibition of rat liver cytochrome P450 isozymes by isothiocyanates and their conjugates: a structure-activity relationship study. Carcinogenesis 1996;17:2423-7.
22. Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci USA 1997;94:10367-72.
23. Borghoff SJ, Birnbaum LS. Age-related changes in the metabolism and excretion of allyl isothiocyanate. A model compound for glutathione conjugation. Drug Metab Dispos 1986;14:417-22.
24. Bruggeman IM, Temmink JH, van Bladeren PJ. Glutathione- and cysteine-mediated cytotoxicity of allyl and benzyl isothiocyanate. Toxicol Appl Pharmacol 1986:83;349-59.
25. Belyaev ND, Keohane AM, Turner BM. Differential underacetylation of histones H2A, H3 and H4 on the inactive X chromosome in human female cells. Human Genet 1996;97:573-8.
26. Goldknopf IL, Rosenbaum F, Sterner R, Vidali G, Allfrey VG, Busch H, Phosphorylation and acetylation of chromatin conjugate protein A24. Biochem Biophys Res Commun 1979;90:269-77.
27. Ohba R, Steger DJ, Brownell JE, Mizzen CA, Cook RG, Cote J, et al. A novel H2A/H4 nucleosomal histone acetyltransferase in Tetrahymena thermophila. Mol Cell Biol 1999;19:2061-8.